TMPRSS2:ERG Fusion Gene and Androgen Ablation Therapy in Prostate Cancer Reply

被引：0
|
作者：
Al-Ahmadie, Hikmat A. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2010年 / 134卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：965 / 965
页数：1
相关论文
共 50 条
  • [21] TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer
    Jiang, Hui
    Mao, Xueying
    Huang, Xiaoyi
    Zhao, Jing
    Wang, Lumei
    Xu, Jingjing
    Zhang, Hongwei
    Lu, Yongjie
    Yu, Yongwei
    TUMOR BIOLOGY, 2016, 37 (09) : 12397 - 12402
  • [22] Molecular Diagnosis of Prostate Cancer: PCA3 and TMPRSS2:ERG Gene Fusion
    Salagierski, Maciej
    Schalken, Jack A.
    JOURNAL OF UROLOGY, 2012, 187 (03): : 795 - 801
  • [23] Microdeletion and concurrent translocation associated with a complex TMPRSS2:ERG prostate cancer gene fusion
    Yoshimoto, Maisa
    Ludkovski, Olga
    Bayani, Jane
    Graham, Cassandra
    Zielenska, Maria
    Squire, Jeremy A.
    GENES CHROMOSOMES & CANCER, 2007, 46 (09): : 861 - 863
  • [24] Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status
    Egbers, Lieke
    Luedeke, Manuel
    Rinckleb, Antje
    Kolb, Suzanne
    Wright, Jonathan L.
    Maier, Christiane
    Neuhouser, Marian L.
    Stanford, Janet L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 181 (09) : 706 - 713
  • [25] TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
    F Demichelis
    K Fall
    S Perner
    O Andrén
    F Schmidt
    S R Setlur
    Y Hoshida
    J-M Mosquera
    Y Pawitan
    C Lee
    H-O Adami
    L A Mucci
    P W Kantoff
    S-O Andersson
    A M Chinnaiyan
    J-E Johansson
    M A Rubin
    Oncogene, 2007, 26 : 4596 - 4599
  • [26] TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
    Demichelis, F.
    Fall, K.
    Perner, S.
    Andren, O.
    Schmidt, F.
    Setlur, S. R.
    Hoshida, Y.
    Mosquera, J-M
    Pawitan, Y.
    Lee, C.
    Adami, H-O
    Mucci, L. A.
    Kantoff, P. W.
    Andersson, S-O
    Chinnaiyan, A. M.
    Johansson, J-E
    Rubin, M. A.
    ONCOGENE, 2007, 26 (31) : 4596 - 4599
  • [27] The fusion of TMPRSS2: ERG and an intronic deletion is associated with hereditary prostate cancer
    Hofer, M. D.
    Kuefer, R.
    Perner, S.
    Maier, C.
    Herkommer, K. ]
    Paiss, T.
    Demichelis, F.
    Vogel, W.
    Hoegel, J.
    Chinnaiyan, A. M.
    Rubin, M. A.
    MODERN PATHOLOGY, 2007, 20 : 152A - 152A
  • [28] Enhanced androgen signalling pathway increases the risk of prostate cancer through induction of TMPRSS2:ERG fusion
    Bastus, Nuria Coll
    Lu, Yong-Jie
    Boyd, Lara K.
    Mao, Xueying
    Stankiewicz, Elzbieta
    Kudahetti, Sakunthala C.
    Oliver, Tim D.
    Berney, Daniel M.
    CANCER RESEARCH, 2011, 71
  • [29] Frequent TMPRSS2/ERG gene fusion in prostate cancer: Identification of fusion variants and correlation to histological grades
    Tu, J. J.
    Kao, J.
    Rohan, S.
    Chen, Y. T.
    MODERN PATHOLOGY, 2007, 20 : 181A - 181A
  • [30] Frequent TMPRSS2/ERG gene fusion in prostate cancer: Identification of fusion variants and correlation to histological grades
    Tu, J. J.
    Kao, J.
    Rohan, S.
    Chen, Y. T.
    LABORATORY INVESTIGATION, 2007, 87 : 181A - 181A
12345